Navigation Links
New Data Published in Neurology Show Once-Daily Lamictal XR Significantly Reduced Partial Seizures in Patients with Epilepsy
Date:10/15/2007

taneous conversion to monotherapy from two or more concomitant AEDs.

Lamictal is also approved for maintenance treatment of bipolar I disorder to delay the time to occurrence of mood episodes (depression, mania, hypomania, mixed episodes) in adult patients treated for acute mood episodes with standard therapy. The effectiveness of Lamictal in the acute treatment of mood episodes has not been established.

Serious rashes requiring hospitalization and discontinuation of treatment have been reported in association with the use of Lamictal. The incidence of these rashes, which have included Stevens-Johnson syndrome, is approximately 0.8 percent (8 per 1000) in pediatric patients under the age of 16 years receiving Lamictal as adjunctive therapy for epilepsy, and 0.3 percent (3 per 1000) in adults on adjunctive therapy for epilepsy. In clinical trials of bipolar and other mood disorders, the rate of serious rash was 0.08 percent of adult patients who received Lamictal as initial monotherapy and 0.13 percent of adult patients who received Lamictal as adjunctive therapy. In a prospectively followed cohort of 1,983 pediatric patients taking adjunctive Lamictal, there was one rash-related death.

About GlaxoSmithKline

GlaxoSmithKline (NYSE: GSK), with U.S. operations in Philadelphia, P.A. and Research Triangle Park, N.C., is one of the world's leading research-based pharmaceutical and healthcare companies. GlaxoSmithKline is committed to improving the quality of human life by enabling people to do more, feel better, and live longer. More information on GlaxoSmithKline is available at the company's Web site at http://www.gsk.com.


'/>"/>
SOURCE GlaxoSmithKline
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. New Phase 3 Study Published in The Lancet Evaluates Efficacy and Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination Therapy in Treatment-Experienced Adults With HIV
2. New Proof of Genisteins Efficacy and Safety for Osteopenia and Osteoporosis Published in Annals of Internal Medicine
3. Bio-Matrix Scientifics Dr. ONeill Sees University of Pittsburghs Published Study on Culture Blood-Forming Stem Cells from Human Fat Tissue as Supporting Near Term Benefits of Banking Adipose (Fat) Derived Stem Cells
4. Interim Analysis of Crinone Pregnancy Study to Be Published in American Society for Reproductive Medicine Journal
5. VIVUS Announces Abstract Published at American Diabetes Association Scientific Sessions
6. Anacor Identifies a Novel Mechanism for Its Lead Anti-Fungal Drug, AN2690; Findings Published in Science
7. Research on New Treatment for Neglected Disease Published in The New England Journal of Medicine
8. Landmark Study Published in the New England Journal of Medicine Shows Important Benefits of Eprodisate (KIACTA) Treatment for Patients with Amyloid A (AA) Amyloidosis
9. Newly Published Data from Large Study Support Cardiovascular Safety of Avandia (Rosiglitazone Maleate)
10. Javelin Pharmaceuticals Phase II Rylomine (Intranasal Morphine) Data Published in Pain Medicine
11. Newly Published Data Demonstrates Superiority of Cipralex Over Duloxetine for Acute Treatment of Depression
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2009)...EUVEN, Belgium and LUND, Sweden, July 3 /PRNewswir...ls: THR) and co-development partner,BioInvent Int...arted,recruitment of a second cohort of patients ...completion of recruitment of the first cohort of 1... long acting anticoagulant that,is being develope...
(Date:7/2/2009)... and WOODCLIFF LAKE, N.J., July 2 ...mp; CEO: Haruo Naito, "Eisai") and Eisai Corporati... NJ, Chairman and CEO Hajime Shimizu) are currentl...for the company,s major product Aricept(R) (donepe...o patients with Alzheimer,s disease. As progress i...
(Date:7/1/2009)...VISTGAARD, Denmark, July 1 /PRNewswire-FirstCall/ ...pert Opinion on Investigational Drugs", Volume,18...formation on,PROSTVAC(TM). This is the most compr...r. , Quote from the article: "Preliminary c..., and Phase II trials have suggested a survival be...
(Date:6/30/2009)...THIAN, Va., June 30 In two recent ...ebulizer and PRONEB compressors (Ultra and Ultra I...arate (Perforomist, DEY LP, Mylan Inc.) improves p...searchers chose PARI products as the exclusive neb...nance treatments for COPD. Sutherland et al. used...
Breaking Medicine Technology:ThromboGenics and BioInvent Start Recruitment of Second 100 Patient Cohort in Phase II DVT Prophylaxis Study With TB-402 2ThromboGenics and BioInvent Start Recruitment of Second 100 Patient Cohort in Phase II DVT Prophylaxis Study With TB-402 3ThromboGenics and BioInvent Start Recruitment of Second 100 Patient Cohort in Phase II DVT Prophylaxis Study With TB-402 4ThromboGenics and BioInvent Start Recruitment of Second 100 Patient Cohort in Phase II DVT Prophylaxis Study With TB-402 5Current Status of the Development Programs of New Indications and Formulations for Aricept(R) for Enhancing Patient Value 2Current Status of the Development Programs of New Indications and Formulations for Aricept(R) for Enhancing Patient Value 3New Review on PROSTVAC(TM) Published by Key Investigators From NCI 2PARI LC Plus and PRONEB Ultra Used in Two Perforomist Studies on Improving COPD Therapies 2LCA Vision Adopts Stockholder Rights Plan 30423 1LCA Vision Adopts Stockholder Rights Plan 30423 2LCA Vision Adopts Stockholder Rights Plan 30423 3Cepheid Receives Health Canada License for First Molecular Diagnostic Test for MRSA and S aureus Soft Tissue Infections 30421 1Cepheid Receives Health Canada License for First Molecular Diagnostic Test for MRSA and S aureus Soft Tissue Infections 30421 2Cepheid Receives Health Canada License for First Molecular Diagnostic Test for MRSA and S aureus Soft Tissue Infections 30421 3Cepheid Receives Health Canada License for First Molecular Diagnostic Test for MRSA and S aureus Soft Tissue Infections 30421 4Tigermed Forms Strategic Partnerships With Leading CROs in Russia and South Korea 30419 1Tigermed Forms Strategic Partnerships With Leading CROs in Russia and South Korea 30419 2Accordia Global Health Foundation Receives 2412 5 Million Grant From Bill 26 Melinda Gates Foundation 30417 1Accordia Global Health Foundation Receives 2412 5 Million Grant From Bill 26 Melinda Gates Foundation 30417 2
...007 - Affymax, Inc.,(Nasdaq:AFFY) today announced ... trials of Hematide(TM) in dialysis and,non-dialys... showed,that in treatment naive, non-dialysis pati...ed monthly at an appropriate dose.,Similarly, the ...three-times weekly Epoetin Alfa demonstrated that ...
...CytRx Corporation,(NASDAQ:CYTR) today announced th... exclusively licensed to its majority-owned,subsid...een,published in the April 2007 issue of peer-revi...technology was developed by RXi,Co-founder, Scient...chusetts Medical School (UMMS) Professor of Bioche...
Other Medicine Technology:Affymax Announces Phase 2 Clinical Trial Results of Once-Per-Month,Hematide for the Treatment of Anemia in Patients with Early- and,End-Stage Chronic Kidney Disease 2Affymax Announces Phase 2 Clinical Trial Results of Once-Per-Month,Hematide for the Treatment of Anemia in Patients with Early- and,End-Stage Chronic Kidney Disease 3CytRx Announces RNAi Delivery Nanoparticle Technology Exclusively,Licensed to Subsidiary, RXi Pharmaceuticals, Described in,Peer-Reviewed Journal 2CytRx Announces RNAi Delivery Nanoparticle Technology Exclusively,Licensed to Subsidiary, RXi Pharmaceuticals, Described in,Peer-Reviewed Journal 3CytRx Announces RNAi Delivery Nanoparticle Technology Exclusively,Licensed to Subsidiary, RXi Pharmaceuticals, Described in,Peer-Reviewed Journal 4
(Date:7/3/2009)... Upstate HomeCare, a home medical ser... medication, respiratory and DME services, is expa...ened. One specializes in home infusion therapy and...state HomeCare. , Clinton...a home medical services provider specializing in i...
(Date:7/2/2009)... July 2 Recent news rep...credentials and ensuring that physicians meet high...ding to the American Board of Medical Specialties ...r Boards in their efforts to develop and implement...aluation and certification of physician specialist...
(Date:7/2/2009)...alth one of 63 businesses honored in Washington, D...SNewswire/ -- Texas Health Resources has receive...d from the National Business Group on Health. , ...0090702/DC41773LOGO ) , , The award recogniz...e programs that promote a healthy workplace and fo...
(Date:7/2/2009)...ep aid shuts down one set of neurons, another set ...ealthDay News) -- New information about brain circ...take the sleep aid Ambien (zolpidem) walk, eat, ta...ke -- and without remembering it the next morning....ally conscious patients into a conscious state. ,...
Breaking Medicine News(10 mins):Health News:Upstate HomeCare Expands, Adds Pharmacies 2Health News:Upstate HomeCare Expands, Adds Pharmacies 3Health News:Seek Out Credentials Before Choosing a Physician - Is Your Cardiologist Board Certified in Cardiovascular Disease? 2Health News:Seek Out Credentials Before Choosing a Physician - Is Your Cardiologist Board Certified in Cardiovascular Disease? 3Health News:Seek Out Credentials Before Choosing a Physician - Is Your Cardiologist Board Certified in Cardiovascular Disease? 4Health News:Texas Health Resources Recognized by National Business Group on Health as Leading Employer Promoting Healthy Lifestyles for Employees 2Health News:Texas Health Resources Recognized by National Business Group on Health as Leading Employer Promoting Healthy Lifestyles for Employees 3Health News:Odd Behaviors on Ambien Linked to Brain Circuitry 2
... medicines may help protect older adults from decl...rding to new research. The drugs that researchers...as ACE inhibitors specifically those types that r...y help reduce the inflammation that might contribu...
...vil society groups, including people living with H...ight HIV/AIDS that has assumed epidemic proportion...f civil society groups, NGOs, media, trade unions,...address various issues from removing stigma to acc...
... used state-of-the-art computational techniques in...ed would be effective lead compounds for breast c... College subsequently synthesized the predicted mo...deed potential anti-breast cancer compounds in ani...
...n hall and scratching ones head might not exactly ...be to move your eyes from side to side for 30 sec...ation sitting, but it might be the only trick to r...es. A study shows that improving memory may be as...
Other Medicine News:Health News:Some High Blood Pressure Drugs may Help Reduce Dementia Risk 2Health News:Various Civil Society Groups Form Alliance to Fight HIV/AIDS 2Health News:Researchers Identifies Molecules That is Effective in Fighting Against Breast Cancer 2Health News:Eyeing a Good Memory - Not an Exercise in Futility! 2
...anal flare index. A/P and lateral fins with holes ...oximal medial hole, humeral / glenoid diametral cu...slation. Rough textured proximal surface to provid...otational resistance in cement, six stem sizes, fi...
BioPro Uni-compartmental Knee System - Uni-compartmental Tibial Tray
The Advance Unicompartmental Knee System is designed with bone conserving femoral and tibial components that provide reproducible results within a minimal incision. Uni metal backed tibial component.
Advance Uni-Comparental Knee Components - Uni All-poly Tibial Component
Medicine Products: